Protection elicited by two glutamine auxotrophs of Mycobacterium tuberculosis and in vivo growth phenotypes of the four unique glutamine synthetase mutants in a murine model

Infection and Immunity

Volumn 74, Issue 11, 2006, Pages 6491-6495

  Lee, Sunhee ^a   Jeon, Bo Young ^b   Bardarov, Svetoslav ^c   Chen, Mei ^a   Morris, Sheldon L ^b   Jacobs Jr , William R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GLUTAMATE AMMONIA LIGASE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BCG VACCINATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; MOUSE; MOUSE STRAIN; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; TUBERCULOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; GLUTAMATE-AMMONIA LIGASE; GLUTAMINE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; TUBERCULOSIS, PULMONARY;

EID: 33750479870     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00531-06     Document Type: Article

References (27)

1. Bardarov, S., S. Bardaroy, Jr., M. S. Pavelka, Jr., V. Sambandamurthy, M. Larsen, J. Tufariello, J. Chan, G. Hatfull, and W. R. Jacobs, Jr. 2002. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148:3007-3017.
2. Castanon-Arreola, M., and Y. Lopez-Vidal. 2004. A second-generation anti TB vaccine is long overdue. Ann. Clin. Microbiol. Antimicrob. 3:10.
3. Centers for Disease Control and Prevention. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. Morb. Mortal. Wkly. Rep. 55:301-305.
4. Dye, C., S. Scheele, P. Dolin, V. Pathania, M. C. Raviglione, et al. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 282:677-686.
5. Fink, D., N. Weissschuh, J. Reuther, W. Wohlleben, and A. Engels. 2002. Two transcriptional regulators GlnR and GlnRII are involved in regulation of nitrogen metabolism in Streptomyces coelicolor A3(2). Mol. Microbiol. 46:331-347.
6. Harth, G., and M. A. Horwitz. 1999. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J. Exp. Med. 189:1425-1436.
7. Harth, G., S. Maslesa-Galic, M. V. Tullius, and M. A. Horwitz. 2005. All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis. Mol. Microbiol. 58:1157-1172.
8. Hondalus, M. K., S. Bardarov, R. Russell, J. Chan, W. R. Jacobs, Jr., and B. R. Bloom. 2000. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 68:2888-2898.
9. Jackson, M., S. W. Phalen, M. Lagranderie, D. Ensergueix, P. Chavarot, G. Marchal, D. N. McMurray, B. Gicquel, and C. Guilhot. 1999. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect. Immun. 67:2867-2873.
10. Kamath, A. T., U. Fruth, M. J. Brennan, R. Dobbelaer, P. Hubrechts, M. M. Ho, R. E. Mayner, J. Thole, K. B. Walker, M. Liu, and P. H. Lambert. 2005. New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development. Vaccine 23:3753-3761.
11. McAdam, R. A., T. R. Weisbrod, J. Martin, J. D. Scuderi, A. M. Brown, J. D. Cirillo, B. R. Bloom, and W. R. Jacobs, Jr. 1995. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect. Immun. 63:1004-1012.
12. Mehta, R., J. T. Pearson, S. Mahajan, A. Nath, M. J. Hickey, D. R. Sherman, and W. M. Atkins. 2004. Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteria. J. Biol. Chem. 279:22477-22482.
13. Merrick, M. J., and R. A. Edwards. 1995. Nitrogen control in bacteria. Microbiol. Rev. 59:604-622.
14. Mutalik, V. K., P. Shah, and K. V. Venkatesh. 2003. Allosteric interactions and bifunctionality make the response of glutamine synthetase cascade system of Escherichia coli robust and ultrasensitive. J. Biol. Chem. 278:26327-26332.
15. Opie, E., and J. Freund. 1937. An experimental study of protective inoculation with heat killed tubercle bacilli. J. Exp. Med. 66:761-788.
16. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Conn, C. S. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, P. Nunn, et al. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. N. Engl. J. Med. 338:1641-1649.
17. Parish, T., J. Lewis, and N. G. Stoker. 2001. Use of the mycobacteriophage L5 excisionase in Mycobacterium tuberculosis to demonstrate gene essentiality. Tuberculosis 81:359-364.
18. Parish, T., and N. G. Stoker. 2000. glnE is an essential gene in Mycobacterium tuberculosis. J. Bacteriol. 182:5715-5720.
19. Pavelka, M. S., Jr., B. Chen, C. L. Kelley, F. M. Collins, and W. R. Jacobs, Jr. 2003. Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 71:4190-4192.
20. Rhee, S. G., P. B. Chock, and E. R. Stadtman. 1989. Regulation of Escherichia coli glutamine synthetase. Adv. Enzymol. Relat. Areas Mol. Biol. 62:37-92.
21. Sambandamurthy, V. K., S. C. Derrick, K. V. Jalapathy, B. Chen, R. G. Russell, S. L. Morris, and W. R. Jacobs, Jr. 2005. Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis. Infect. Immun. 73:1196-1203.
22. Sambandamurthy, V. K., and W. R. Jacobs, Jr. 2005. Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis. Microbes Infect. 7:955-961.
23. Sambandamurthy, V. K., X. Wang, B. Chen, R. G. Russell, S. Derrick, F. M. Collins, S. L. Morris, and W. R. Jacobs, Jr. 2002. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat. Med. 8:1171-1174.
24. Sampson, S. L., C. C. Dascher, V. K. Sambandamurthy, R. G. Russell, W. R. Jacobs, Jr., B. R. Bloom, and M. K. Hondalus. 2004. Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs. Infect. Immun. 72:3031-3037.
25. Tullius, M. V., G. Harth, and M. A. Horwitz. 2003. Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect. Immun. 71:3927-3936.
26. Weisschuh, N., D. Fink, S. Vierling, M. J. Bibb, W. Wohlleben, and A. Engels. 2000. Transcriptional analysis of the gene for glutamine synthetase II and two upstream genes in Streptomyces coelicolor A3(2). Mol. Gen. Genet. 264:461-469.
27. Wray, L. V., Jr., M. R. Atkinson, and S. H. Fisher. 1991. Identification and cloning of the glnR locus, which is required for transcription of the glnA gene in Streptomyces coelicolor A3(2). J. Bacteriol. 173:7351-7360.